Clinical Trial Update: Red Cell Half Life Determination in Patients With and Without Sickle Cell Disease [EARLY_Phase 1]

View source ↗

Summary

Early-phase 1 clinical trial evaluating red blood cell half-life in patients with and without sickle cell disease; study completed with results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Sickle Cell Disease, Sickle Cell Anemia | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2024-02-13